Richard M. Stone

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

May, 2025

Richard M. Stone

Dec 23, 2024, 11:55 | Drugs

Talha Badar: Venetoclax and Azacitidine for elderly AML ineligible for intensive Induction

Talha Badar shared on X: “Brief overview of venetoclax+azacitidine for elderly AML ineligible for intensive…

Sep 26, 2024, 15:39 | Insight

Article of the Week, Suggested by the BPDCN International Registry

Immune Oncology Research Institute shared a post on LinkedIn: "Article of the Week Suggested by the…

Aug 10, 2024, 03:56 | Insight

Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia

Bichoy Gabra, Oncology Infusion Pharmacy Services Manager at Moffitt Cancer Center, shared on X: "Many…

Jul 25, 2024, 21:01 | Blog

Caner Saygin: A testament to the fact that flow MRD is insufficient for making treatment decisions in ALL

Caner Saygin, Assistant Professor of Medicine at University of Chicago, shared a post by NEJM, on X:…

May 18, 2024, 12:07 | Insight

Amer Zeidan: Another great project led by super star Maximilian Stahl

Amer Zeidan shared a post on X: “Another great project led by super star Maximilian Stahl…

All: 5 Posts: 1 - 100

'

Francesco Acerbi and Testicular Cancer: The Defender's Fight and Triumphant Return to Football

'

Yvonne Award for Breakthrough Research 2024 Recipient to Time100 Health List

'

Dr Saunthari Somasundaram is the new President-Elect of the NCD Alliance

'

Does Plastic Cause Cancer? Myths and Facts

'

TOPGEAR trial at ESTRO 2025: Preoperative Chemoradiotherapy for Resectable Gastric Cancer

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023